Background:
Inflammatory processes have been suggested to underlie early neurologic abnormalities among persons living with HIV (HIV-positive), such as deficits in complex motor function, that are purported to remit with effective antiretroviral treatment (ART). We hypothesized HIV will have negative direct and indirect effects via inflammation on complex motor performance.
Methods:
The sample consisted of 90 ART-treated virally suppressed HIV-positive and 94 HIV-negative adults, ages 36 to 65 years, with balanced recruiting in each age decade (36–45, 46–55, 56–65). Biomarkers of inflammation (d-dimer, IL-6, MCP-1/CCL2, sCD14, and TNF-α) were measured, and a composite inflammation burden score was calculated. Complex motor performance was evaluated using the Grooved Pegboard Test.
Results:
The HIV-positive group had worse complex motor performance (p = 0.001; hedge’s g = −0.49) and a higher average inflammation burden composite score (p < 0.001; hedge’s g = 0.78) than the HIV-negative group. Path analyses indicated that the indirect effect of HIV disease on complex motor performance through inflammation burden was statistically significant, accounting for 15.1% of the effect of HIV on complex motor performance.
Conclusion:
Although neurologic findings (e.g., deficits in motor speed/dexterity) commonly associated with HIV infection typically remit with ART, our analysis indicates that inflammation plays an important role in worse complex motor skills among HIV-positive adults. Future studies of strategies for managing chronic inflammation in HIV should consider using an inflammation burden composite and examining its effect on complex motor performance.